{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:56:05Z","timestamp":1761418565323,"version":"3.35.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1994,7]]},"DOI":"10.1136\/ard.53.7.471","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"471-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate."],"prefix":"10.1016","volume":"53","author":[{"given":"C.D.","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.T.","family":"Fawcett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Gibney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Doughty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.H.","family":"Singsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.1780311103","article-title":"Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation","volume":"31","author":"H, Campen D.; A, Horwitz D.; P, Jr, Quismorio F.; R, Ehresmann G.; J, Martin W.","year":"1988","unstructured":"Campen D H, Horwitz D A, Quismorio F P Jr, Ehresmann G R, Martin W J. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 1988; 31: 1358-64.","journal-title":"Arthritis Rheum"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.1780330814","article-title":"The soluble interleukin-2 receptor in rheumatic disease","volume":"33","author":"A, Rubin L.","year":"1990","unstructured":"Rubin L A. The soluble interleukin-2 receptor in rheumatic disease. Arthritis Rheum 1990; 33: 1145-48.","journal-title":"Arthritis Rheum"},{"key":"ref_3","first-page":"908","article-title":"Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: Effect of chlorambucil..7 Rheumatol","volume":"17","author":"J, Clements P.; B, Peter J.; S, Agopian M.; S, Telian N.; E, Furst D.","year":"1990","unstructured":"Clements P J, Peter J B, Agopian M S, Telian N S, Furst D E. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: Effect of chlorambucil..7 Rheumatol 1990; 17: 908-10."},{"key":"ref_4","first-page":"597","article-title":"Serial levels of soluble interleukin 2 receptor in rheumatoid the peripheral blood arthritis: Correlation with odfisepaasteieancttsivitwyi.tJh Rheumnatol","volume":"17","author":"A, Rubin L.","year":"1990","unstructured":"Rubin L A, Snow K M, Kurman C C, Nelson D L, Keystone E C. Serial levels of soluble interleukin 2 receptor in rheumatoid the peripheral blood arthritis: Correlation with odfisepaasteieancttsivitwyi.tJh Rheumnatol 1990; 17: 597-602."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780330713","article-title":"Interleukin 1-a, Interleukin-2 and soluble interleukin-2 receptors in polymyositis","volume":"33","author":"E, Wolf R.; A, Baethge B.","year":"1990","unstructured":"Wolf R E, Baethge B A. Interleukin 1-a, Interleukin-2 and soluble interleukin-2 receptors in polymyositis. Arthritis Rheum 1990; 33: 1007-11.","journal-title":"Arthritis Rheum"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780350914","article-title":"Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis: Evidence of T-cell activation","volume":"35","author":"H, Schmitt W.; C, Heesen; E, Csernok; A, Rautmann; L, Gross W.","year":"1992","unstructured":"Schmitt W H, Heesen C, Csernok E, Rautmann A, Gross W L. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis: Evidence of T-cell activation. Arthritis Rheumz 1992; 35: 1088-96.","journal-title":"Arthritis Rheumz"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/art.1780310704","article-title":"soluble IL-2 of patients receptor levels in with rheumatoid the sera and synovial fluids arthritis","volume":"31","author":"C, Keystone E.","year":"1988","unstructured":"Keystone E C, Know K M, Bomardier C, et al. Elevated soluble IL-2 of patients receptor levels in with rheumatoid the sera and synovial fluids arthritis. Arthritis Rheumt 1988; 31: 844-9.","journal-title":"Arthritis Rheumt"},{"key":"ref_8","first-page":"36","article-title":"Soluble serum IL-2 receptor levels in refractory RA: trends during MTX therapy","volume":"34","author":"A, Dooley M.; S, Pisetsky D.; V, Dawson D.; P, Polisson R.","year":"1991","unstructured":"Dooley M A, Pisetsky D S, Dawson D V, Polisson R P. Soluble serum IL-2 receptor levels in refractory RA: trends during MTX therapy. Arthritis Rheum 1991; 34: S36.","journal-title":"Arthritis Rheum"},{"key":"ref_9","first-page":"78","article-title":"Soluble interleukin-2 receptors (IL-2R) in children with juvenile rheumatoid arthritis (JRA)","volume":"31","author":"S, Barron K.; F, Montalvo J.; K, Saadeh C.; M, Orson F.","year":"1988","unstructured":"Barron K S, Montalvo J F, Saadeh C K, Orson F M. Soluble interleukin-2 receptors (IL-2R) in children with juvenile rheumatoid arthritis (JRA). Arthritis Rheumn 1988; 31: S78.","journal-title":"Arthritis Rheumn"},{"key":"ref_10","first-page":"195","article-title":"Current proposed revision of JRA criteria","volume":"20","author":"J, Brewer E.","year":"1977","unstructured":"Brewer E J, Bass J, Baum J, et al. Current proposed revision of JRA criteria. Arthritis Rheum 1977; 20(suppl): 195-9.","journal-title":"Arthritis Rheum"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02900713","article-title":"Interleukin- 2, soluble interleukin-2 receptor and tumor necrosis factor in sera from patients with rheumatoid arthritis","volume":"20","author":"Corvetta, A.; M, Luchetti M.; Pomponio, G.","year":"1990","unstructured":"Corvetta A, Luchetti M M, Pomponio G, et al. Interleukin- 2, soluble interleukin-2 receptor and tumor necrosis factor in sera from patients with rheumatoid arthritis. Res Clin Lab 1990; 20: 275-81.","journal-title":"Res Clin Lab"},{"key":"ref_12","first-page":"579","article-title":"Simultaneous evaluation of membrane bound and soluble interleukin-2 receptor expression in the blood and synovial fluid of patients with rheumatoid arthritis","volume":"8","author":"Vaisberg, M.; A, Scheinberg M.","year":"1990","unstructured":"Vaisberg M, Scheinberg M A. Simultaneous evaluation of membrane bound and soluble interleukin-2 receptor expression in the blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 1990; 8: 579-82.","journal-title":"Clin Exp Rheumatol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0090-1229(90)90023-J","article-title":"Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritis","volume":"57","author":"C, Zielinski C.; B, Pesau; C, Muller","year":"1990","unstructured":"Zielinski C C, Pesau B, Muller C. Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritis. Clin Immunol Immunopathol 1990; 57: 74-82.","journal-title":"Clin Immunol Immunopathol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00918193","article-title":"et at Interleukin-2 (IL-2) in rheumatoid synovial fluid: Correlation with prognosis and soluble IL-2 receptor levels","volume":"10","author":"Miossec, P.; Elhamiani, M.; Chichehian, B.","year":"1990","unstructured":"Miossec P, Elhamiani M, Chichehian B, et at Interleukin-2 (IL-2) in rheumatoid synovial fluid: Correlation with prognosis and soluble IL-2 receptor levels. Clin Immunol 1990; 10: 115-20.","journal-title":"Clin Immunol"},{"key":"ref_15","first-page":"74","article-title":"Low dose cyclosporine A in psoriatic arthritis: Relation between soluble interleukin 2 receptors and response to therapy","volume":"19","author":"Salvarani, C.; Macchioni, P.; Boiardi, L.","year":"1992","unstructured":"Salvarani C, Macchioni P, Boiardi L, et al. Low dose cyclosporine A in psoriatic arthritis: Relation between soluble interleukin 2 receptors and response to therapy. JRheumatol 1992; 19: 74-9.","journal-title":"JRheumatol"},{"key":"ref_16","first-page":"831","article-title":"Soluble Interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in systemic lupus erythematosus","volume":"18","author":"Raziuddin, S.; A, Al-Janadi M.; A, Al-Wabel A.","year":"1991","unstructured":"Raziuddin S, Al-Janadi M A, Al-Wabel A A. Soluble Interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in systemic lupus erythematosus. Rheumatol 1991; 18: 831-6.","journal-title":"Rheumatol"},{"key":"ref_17","first-page":"77","article-title":"The usefulness of measuring soluble interleukin-2 receptor levels in children with Kawasaki syndrome","volume":"31","author":"S, Barron K.; F, Montalvo J.; K, Saadeh C.","year":"1988","unstructured":"Barron K S, Montalvo J F, Saadeh C K, et al. The usefulness of measuring soluble interleukin-2 receptor levels in children with Kawasaki syndrome. Arthritis Rheum 1988; 31: S77.","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724405104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724405104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.53.7.471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:20:13Z","timestamp":1738304413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724405104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1994,7]]}},"alternative-id":["S0003496724405104"],"URL":"https:\/\/doi.org\/10.1136\/ard.53.7.471","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1994,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.53.7.471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1994 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}